Life-Changing Weight Loss
At LIVVE, weight-management treatment is clinically led, supportive and individualised.
Weight-management injections are used as part of a holistic health approach, alongside lifestyle, nutrition and wellbeing support.
Prescription Weight-Management Injections

Wegovy® & Mounjaro®
At LIVVE, we offer clinically prescribed weight-management injections as part of a safe, supportive and medically led service. These treatments are not quick fixes and are only prescribed following a full clinical assessment.
We currently prescribe Wegovy® (semaglutide) and Mounjaro® (tirzepatide), where clinically appropriate.
What's the difference?
Wegovy®
Mounjaro®
FAQ's
-
Both Wegovy® and Mounjaro® work by supporting the body’s natural appetite-regulating hormones. They can help you:
- Feel fuller for longer
- Reduce appetite and food cravings
- Improve portion control
They are taken as a once-weekly injection and are most effective when used alongside healthy lifestyle changes.
-
Wegovy® contains semaglutide, which mimics a hormone (GLP-1) involved in appetite regulation.
It may be suitable for people who:
- Are new to prescription weight-management treatment
- Prefer a well-established GLP-1 option
- Meet clinical eligibility criteria following assessment
-
Mounjaro® contains tirzepatide, which acts on two appetite-regulating pathways (GIP and GLP-1).
Some patients may experience:
- Stronger appetite suppression
- Improved satiety
- Greater weight-loss response
Suitability depends on individual medical history and clinical assessment.
-
These treatments are not suitable if you:
- Are pregnant or breastfeeding
- Have certain thyroid conditions (including medullary thyroid cancer or MEN2)
- Have specific gastrointestinal conditions
Common side effects may include nausea, vomiting, diarrhoea or constipation, particularly when doses are increased. These will be discussed fully during your consultation.
-
These medications are prescription-only and are not suitable for everyone.
You may be considered if you:
- Have a BMI of 30 kg/m² or above, or
- Have a BMI of 27 kg/m² or above with a weight-related health condition (such as type 2 diabetes, high blood pressure, raised cholesterol or sleep apnoea)
Eligibility also depends on your:
- Medical history
- Current medications
- Previous weight-management treatments
A prescription will only be issued if clinically appropriate.
How to get started
Products
We currently prescribe Wegovy® (semaglutide) and Mounjaro® (tirzepatide), where clinically appropriate. The most appropriate option will be discussed during your consultation.
Not sure which option is right for you?
Our short online questionnaire helps us understand your weight-loss goals and medical background. This allows your consultation to focus on the most appropriate treatment for you.
Our Approach at LIVVE

At LIVVE, weight-management treatment is clinically led, supportive and individualised.
We ensure that:
- Medication is never supplied without a consultation
- Treatment is prescribed only after clinical assessment
- A video consultation is provided with each new supply of treatment, allowing us to:
- Review progress and response
- Support your goals and ongoing journey
- Adjust treatment where clinically appropriate
- Ongoing monitoring and follow-up are built into your care
Weight-management injections are used as part of a holistic health approach, alongside lifestyle, nutrition and wellbeing support.
Why Livve?
#LIVVE.
@livve.uk Tag us in your posts on Instagram for a chance to feature in our gallery!
- Choosing a selection results in a full page refresh.